Home / Musculoskeletal system / Denosumab
ATC M05BX04 · Drugs for Treatment of Bone Diseases
Denosumab shortage
As of 31 Oct 2026, Denosumab has a reported shortage in 1 of the 5 countries we track (Italy), covering 7 products.
Countries1/5
Products7packs or presentations
Short since9 Jun 20265 months ago
Earliest returnnot givencompany estimate
No return date7products
Main reasonIncreased demand
Timeline
Italy
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | STOBOCLO | CELLTRION HEALTHCARE HUNGARY KFT | 9 Jun 2026 | not given | Increased demand Elevata richiesta |
| IT | JUBEREQ | ACCORD HEALTHCARE, S.L.U. | 26 Jun 2026 | not given | Increased demand Elevata richiesta |
| IT | OSENVELT | CELLTRION HEALTHCARE HUNGARY KFT | 29 Jun 2026 | not given | Increased demand Elevata richiesta |
| IT | BILDYOS | SCIENCEPHARMA SPÓLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA | 8 Jul 2026 | not given | Increased demand Elevata richiesta |
| IT | OBODENCE | SAMSUNG BIOEPIS NL B.V. | 10 Aug 2026 | not given | Increased demand Elevata richiesta |
| IT | BOMYNTRA | FRESENIUS KABI DEUTSCHLAND GMBH | 21 Sep 2026 | not given | Increased demand Elevata richiesta: distribuzione contingentata |
| IT | OSVYRTI | ACCORD HEALTHCARE, S.L.U. | 28 Sep 2026 | not given | Manufacturing problem Problemi produttivi |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.